Inclusion body myositis (IBM) is the most prevalent muscle-wasting disease ... work impairment and premature death.1–9 Treatment options have attempted to target inflammatory, degenerative, and ...

Funding was led by New Enterprise Associates, with participation from Foresite Capital and multiple other investors. Abcuro announced that it has obtained $200 million in Series C financing, led by ...

The former frontman of Humble Pie, Frampton, retired from playing live music in 2019 after he was diagnosed with Inclusion Body Myositis. However, last year, the 74-year-old musician declared that ...

Sporadic inclusion body myositis (sIBM) presents with a characteristic clinical phenotype of slow-onset weakness and atrophy, affecting proximal and distal limb muscles and facial and pharyngeal ...

Ulviprubart is designed to treat diseases mediated by highly cytotoxic T cells, including the autoimmune muscle disease inclusion body myositis (IBM) and T cell large granular lymphocytic leukemia ...

Proceeds to support completion of the registrational Phase 2/3 MUSCLE trial of ulviprubart in inclusion body myositis, BLA filing, and commercial launch preparation NEWTON, Mass.--(BUSINESS ...

sIBM is a complex disorder, the underlying cause of which is unclear. The observation that the intact muscle fibers are invaded by T lymphocytes, whereas the vacuolated fibers lack T-cell ...

Exposures to silica dust, solvents or heavy metals increase the likelihood of developing various forms of myositis, ...

Rock & Roll Hall of Fame inductee and Grammy Award-winning guitarist, Peter Frampton, has unveiled a slew of additional shows ...

A founding member of Humble Pie, Frampton went on to enjoy a lengthy solo career. “Frampton Comes Alive” wasn’t just his breakthrough — it was, by light years, his largest commercial success. One of ...

Objectives Myositis is a heterogeneous family of diseases that includes dermatomyositis (DM), antisynthetase syndrome (AS), immune-mediated necrotising myopathy (IMNM), inclusion body myositis (IBM), ...